000 | 02041cgm a2200421 a 4500 | ||
---|---|---|---|
001 | HST4116 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 190904s2019 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a4116 _bHenry Stewart Talks |
035 | _a(UkLoHST)3150 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aSanyal, Arun J. _4spk |
|
245 | 1 | 0 |
_aNASH _h[electronic resource] : _bevaluation and treatment / _cArun J. Sanyal. |
260 |
_aLondon : _bHenry Stewart Talks, _c2019. |
||
300 |
_a1 online resource (1 streaming video file (50 min.) : _bcolor, sound). |
||
490 | 1 |
_aThe biomedical & life sciences collection, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
500 | _aUpdated version of a talk first published in 2015 under the title: NASH : update on diagnostics and therapy. | ||
505 | 0 | _aContents: NAFLD as a global problem and driver of liver-related burden of disease -- Managing NAFLD in 3 simple steps -- Diagnostic accuracy and performance (CAP) -- Increased risk of mortality by fibrosis stage -- Restoring health for patients with NAFLD -- Key concepts in approach to treatment of NASH -- Various therapeutic options & clinical trials for treatment of NASH. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 | _aFatty liver. | |
650 | 0 |
_aLiver _xDiseases _xDiagnosis. |
|
650 | 0 |
_aLiver _xDiseases _xTreatment. |
|
650 | 2 | _aDisease Management. | |
650 | 2 | _aDisease Progression. | |
650 | 2 |
_aNon-alcoholic Fatty Liver Disease _xdiagnosis. |
|
650 | 2 |
_aNon-alcoholic Fatty Liver Disease _xepidemiology. |
|
650 | 2 |
_aNon-alcoholic Fatty Liver Disease _xphysiopathology. |
|
650 | 2 |
_aNon-alcoholic Fatty Liver Disease _xtherapy. |
|
740 | 0 | _aNASH : update on diagnostics and therapy. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/3150/ |
999 |
_c76171 _d76171 |